Infliximab as an alternative therapy for refractory adult onset Kawasaki disease-Reference-Cited by-同舟云学术

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease

Published:2018-10 Issue:40 Volume:97 Page:e12720
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kawaguchi Takeshi,Rikitake Yuki,Tsuruda Toshihiro,Kawata Chihiro,Rikitake Mao,Iwao Kosho,Aizawa Ayako,Kariya Yumi,Matsuda Motohiro,Miyauchi Syunichi,Umekita Kunihiko,Takajo Ichiro,Okayama Akihiko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children;Kawasaki;Arerugi,1967

2. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome;Kato;J Pediatr,1975

3. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease;Rowley;J Infect Dis,2011

4. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome;Newburger;N Engl J Med,1991

5. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study;Son;J Pediatr,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Cases of Adult-onset Kawasaki Disease with a Difficult Diagnosis;Internal Medicine;2023-11-01

2. Two Distinct Cases of Adult-onset Kawasaki Disease;Internal Medicine;2022-12-01

3. Adult-onset recurrent Kawasaki disease: an unusual cause of fever of unknown origin;BMJ Case Reports;2021-08